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ABSTRACT
Intronic GGGGCC repeat expansions in C9orf72 are the most
common genetic cause of amyotrophic lateral sclerosis (ALS) and
frontotemporal dementia (FTD). Two major pathologies stemming
from the hexanucleotide RNA expansions (HREs) have been
identified in postmortem tissue: intracellular RNA foci and repeat-
associated non-ATG dependent (RAN) dipeptides, although it is
unclear how these and other hallmarks of disease contribute to the
pathophysiology of neuronal injury. Here, we describe two novel
lines of mice that overexpress either 10 pure or 102 interrupted
GGGGCC repeats mediated by adeno-associated virus (AAV) and
recapitulate the relevant human pathology and disease-related
behavioural phenotypes. Similar levels of intracellular RNA foci
developed in both lines of mice, but only mice expressing 102
repeats generated C9orf72 RAN pathology, neuromuscular junction
(NMJ) abnormalities, dispersal of the hippocampal CA1, enhanced
apoptosis, and deficits in gait and cognition. Neither line of mice,
however, showed extensive TAR DNA-binding protein 43 (TDP-43)
pathology or neurodegeneration. Our data suggest that RNA foci
pathology is not a good predictor of C9orf72 RAN dipeptide
formation, and that RAN dipeptides and NMJ dysfunction are
drivers of C9orf72 disease pathogenesis. These AAV-mediated
models of C9orf72-associated ALS/FTD will be useful tools for
studying disease pathophysiology and developing new therapeutic
approaches.
KEYWORDS: C9orf72, Neurodegeneration, ALS/FTD, Mouse model,
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INTRODUCTION
Hexanucleotide repeat expansions (HREs) in C9orf72 are regarded
as the most common genetic cause of the progressive
neurodegenerative diseases, amyotrophic lateral sclerosis (ALS)
and frontotemporal dementia (FTD). ALS primarily affects motor
neurons and leads to progressive failure of the neuromuscular
system with muscle wasting and paralysis, while frontotemporal
dementia (FTD) is caused by the degeneration of neurons in the
frontal and temporal lobes, leading to cognitive deficits. GGGGCC
(G4C2) repeat expansions in the first intron ofC9orf72 are present in
up to 40% of familial ALS and 25% of familial FTD patients, and
are also present in 5-20% of sporadic ALS patients (DeJesus-
Hernandez et al., 2011; Renton et al., 2011, 2014; Majounie et al.,
2012). Normal healthy C9orf72 alleles contain between 2 and 30
repeats, whereas disease-associated alleles vary in size and can
exceed several thousand HREs (DeJesus-Hernandez et al., 2011;
Renton et al., 2011). Three different pathological alterations
providing clues to the etiology of C9orf72-related disease can be
found in post-mortem tissue from patients with HREs: first, a
reduction in all three mRNA transcripts generated from C9orf72,
suggesting that disease may arise by a loss-of-function mechanism
(DeJesus-Hernandez et al., 2011; Belzil et al., 2013; Donnelly et al.,
2013); second, formation of intracellular foci by aggregation of
RNA expansions; and third, dipeptide repeat proteins (DPRs) which
are generated from long expansions via repeat-associated non
ATG-dependent (RAN) translation (Cooper-Knock et al., 2014;
Schludi et al., 2015).
Recent studies suggest that G4C2 expansions and DPRs may
induce cell toxicity by sequestration of RNA binding proteins
(Cooper-Knock et al., 2014; Lee et al., 2016) and disruption of
nucleocytoplasmic transport (Zhang et al., 2015; Freibaum et al.,
2015). Models designed to mimic either C9orf72 haploinsufficiency
or toxic gain of function have been developed to identify the
combination of factors inducing relevant disease pathology. While
C9orf72-knockout mice display motor and cognitive deficits along
with heightened neuroinflammation, these mice do not exhibit any
significant neuronal pathology, suggesting that a simple loss-of-
function mechanism is unlikely to be the sole cause of C9orf72-
linked neurodegeneration (Koppers et al., 2015; O’Rourke et al.,
2016). Four different toxic gain-of-functionmousemodels developed
through expression of patient-derived C9orf72 containing hundreds
of HREs consistently displayed intracellular RNA foci and DPRs in
the CNS, though they differed in the generation of ALS/FTD disease
phenotypes (Jiang et al., 2016; Liu et al., 2016; O’Rourke et al., 2015;
Peters et al., 2015; Chew et al., 2015). In contrast, acute
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mice recapitulates ALS-like pathology and induces cognitive and
behavioural deficits, despite the lack of any flanking C9orf72
sequence (Chew et al., 2015).
Interruptions in repeat expansions are found in alleles for
spinocerebellar ataxia (SCA) (Chung et al., 1993; Pearson et al.,
1998a; Matsuura et al., 2006), myotonic dystrophy type 1 (Musova
et al., 2009), Friedreich ataxia (Stolle et al., 2008) and fragile X
syndromes (Eichler et al., 1994; Pearson et al., 1998a), although the
consequences of the interruptions on disease etiology remain
unclear. Interrupting the expression of pure glycine-alanine (GA)
dipeptide repeats with proline residues in mice prevented the
formation of dense ubiquitin-positive inclusions and the
development of behavioural phenotypes and pathological
hallmarks consistent with C9orf72-ALS/FTD (Zhang et al.,
2016). An interruption in the expression of DPRs created by
inserting stop codons between G4C2 repeats in Drosophila blocked
DPR formation and neurodegeneration but preserved RNA foci
generation demonstrating that DPRs are toxic (Mizielinska et al.,
2014). Here, we generated mice expressing HREs, utilizing AAV
serotype 9 (AAV9) to achieve an acute, widespread expression
following cisterna magna delivery in postnatal day 1 (P1) pups. We
compared mice expressing 10 HRE expansions with mice
expressing 102 repeats interrupted at regular intervals to examine
the effects of interrupted expansions on disease etiology. We show
that both AAV-(G4C2)10 and AAV-(G4C2)102 repeats lead to the
formation of a similar number of intranuclear RNA foci in the CNS
in vivo, but only (G4C2)102 transgenic mice generate DPRs and p62
inclusions, have Purkinje cell apoptosis, exhibit neuromuscular
junction pathology, and display gait and cognitive deficits.
RESULTS
Injection of AAV9 HREs repeats leads to intranuclear RNA
foci in vivo
In these studies, we used self-complementary AAV9, due to its
enhanced CNS transduction efficiency compared with single-
stranded AAV9 (McCarty et al., 2001) and its ability to achieve
transduction in multiple regions of the mouse brain (Lukashchuk
et al., 2016). To generate mice expressing HREs, we first
constructed two separate AAV9 vectors containing either 10 or
102 HREs (Fig. 1A). The AAV9-(G4C2)
102 (referred to as HRE-
102) construct was made by ligating between 10-17 HREs separated
by a short TCGAG linker sequence, which interrupts the sequence
without introducing a stop codon, resulting in mixed dipeptide
proteins. The advantages to using this approach are: firstly, the
interruptions potentially stabilized the sequence, reducing the risk
of DNA rearrangements between the flanking inverted terminal
repeats (ITRs) of the AAV; secondly, we could test whether
C9orf72-mediated pathological hallmarks, such as DPRs, p62
inclusions and TDP-43 aggregation, still persist in the presence of
interrupted repeat sequences.
Mice expressing repeat expansions were generated by delivering
AAV9-HREs to early postnatal (P1) mice via the cisterna magna,
which resulted in widespread transduction of the adult mouse brain
as described in our previous work (Lukashchuk et al., 2016).
Twelve months after AAV9 delivery, mice were killed and different
brain and spinal cord tissue analysed using RNA fluorescent in situ
hybridization (FISH) to see whether intracellular RNA foci were
present. We found that the regions with the highest number of RNA
foci per area were the brain stem, Purkinje cell layer of the
cerebellum, CA1 and hilus of the hippocampus, midbrain and cortex
(Fig. 1B-D). RNA foci were also detected in the spinal cord, even
though they were less numerous in this region (Fig. 1E). The
majority of RNA foci were intranuclear (Fig. 1D-E, white
arrowhead), but we also detected perinuclear foci (Fig. 1F,G,
arrows) and occasionally observed cytoplasmic foci (Fig. 1F,
yellow arrowhead). There were no significant differences in the
number of RNA foci between the HRE-10 and HRE-102 mice in
any of the regions examined (Fig. 1H).
HRE-102 mice exhibit extensive DPR pathology, enhanced
p62 expression and dispersed CA1 neurons
To test whether the AAV9-engineered mouse model develops other
pathological hallmarks of ALS/FTD such as C9orf72-derived RAN
(c9RAN) protein aggregates, TDP-43 inclusions and neuronal loss,
we used an anti-poly-GA antibody (Mackenzie et al., 2013) to probe
for glycine-alanine-rich DPRs in mouse brains. As shown in Fig. 2,
we detected either a homogenous nuclear expression (arrow) or an
intense, discrete staining (arrowhead) within and outside the
nucleus (Fig. 2A). These poly-GA pathologies were most widely
distributed in the cerebellum and brain stem, and visible only in
HRE-102-treated mice (poly-GA detected in 4 out of 6 mice), and
absent in HRE-10-expressing mice (poly-GA detected in 0 out of 6
mice). Triton-insoluble and Triton-soluble cerebellar/brain stem
lysates were found to contain several poly-GA peptides ranging
from 25 to 63 kDa in a subset of HRE-102 mice, but not in HRE-10
mice (Fig. 2B). Additionally, the expression of p62, a marker of
cargo destined for autophagic degradation (Bjorkoy et al., 2005;
Komatsu et al., 2007) and c9RAN pathology (Mori et al., 2013a,b;
Schludi et al., 2015), was enhanced in the cerebellum of HRE-102
mice (Fig. 2C), and was detected in dense intracellular (arrows) and
extracellular (arrowheads) aggregates in HRE-102 mice (Fig. 2D).
Next, we examined the expression of cleaved poly (ADP-ribose)
polymerase (PARP) and cleaved caspase-3 to see whether there was
evidence of cells undergoing apoptosis. We focused our analysis on
the cerebellum, due to the heightened DPR and p62 expression we
observed in the HRE-102 mice (Fig. 2A-D), which has previously
been found to cause cell toxicity (Lee et al., 2016; Lopez-Gonzalez
et al., 2016; Tran et al., 2015). As shown in Fig. 2E-G, we found that
cleaved PARP in cerebellar Purkinje cells (Fig. 2E-F) and cleaved
caspase-3 expression (Fig. 2G) in the cerebellum were significantly
increased in HRE-102 mice, indicating that these areas were in the
early stages of cell death. Interestingly, despite the presence of RNA
foci and c9RAN pathology, neither astrogliosis (Fig. S1) nor
neurodegeneration in the cerebellum (Fig. S2C,D) was observed.
This absence of repeat-length-dependent neurodegeneration was
also observed in other regions such as the cortex (Fig. S2A-B),
spinal cord (Fig. S2E-F) and hippocampus (Fig. 2H,I), although
there was a significant dispersal in the CA1 (Fig. 2H,I) that is
characteristic of reeler mutant mice (Howell et al., 1997;
Trommsdorff et al., 1999). Additionally, although we were able
to detect infrequent TDP-43 aggregates (Fig. S3A-B) in the
cerebellum, cortex, midbrain and hippocampus of HRE-10 and
HRE-102, there was no significant difference between mouse
groups with respect to TDP-43 pathology. We also did not detect
any differences between the groups with respect to phosphorylated
TDP-43 pathology (J.S.C., unpublished observations). In contrast to
the largely nuclear TDP-43 pathology reported by Chew et al.
(2015), the majority of TDP-43 aggregates in both groups of
AAV-HRE-injected mice were cytoplasmic (Fig. S3C).
HRE-102 mice develop disease-related neuromuscular
junction (NMJ) pathology
In the absence of a significant loss of neuronal cell bodies in the
CNS in both mouse cohorts and since NMJ pathology is present in
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several different mouse models of ALS (Iguchi et al., 2013; Frey
et al., 2000; Murray et al., 2010; Bennett et al., 2014), we asked
whether peripheral neuromuscular junctions were altered in the
HRE-102-expressing mice. To do this, muscles from 12-month-old
mice were double-labelled with an anti-neurofilament antibody to
label nerve terminals and fluorescent bungarotoxin to label
acetylcholine receptors (AChRs), and NMJs were imaged with a
confocal microscope. A close inspection of NMJs revealed a
significant increase in pathological NMJs (abnormal pre-synaptic
neurofilament accumulations and/or nerve terminal blebbings) in
HRE-102 mice (Fig. 3A,B), indicating that the NMJ may be an
early target of C9orf72-related toxicity. It is well established that
the density of postsynaptic acetylcholine receptors (AChRs) is
significantly reduced in mouse models of motor neurons disease
and myasthenia gravis (Losen et al., 2005; Kong et al., 2009). Here,
we asked whether the density of AChRs at NMJs of HRE-102 mice
is also altered. AChRs were labelled with BTX-594 and the density
of AChRs at NMJs of HRE-102, HRE-10 and PBS was compared
(Fig. 3C,D). The total fluorescence of AChRs (fluorescence of a
synapse per area of the synapse) was decreased by 20% in muscles
expressing HRE-102 compared with NMJs of PBS-injected mice.
These results indicate that HRE-102 expression reduces the density
of AChRs at postsynaptic sites. Collectively, HRE-102 mice exhibit
a loss in NMJ integrity at 12 months of age that is consistent with the
early stages of motor neuron degeneration.
HRE-102 mice have progressive gait and behavioural deficits
To assess whether the c9RAN and NMJ pathology have any
consequences on mouse behaviour, we analysed motor and
cognitive tasks. We used a Catwalk system to examine different
parameters measuring motor coordination and gait in ambulatory
mice, and found that HRE-102 mice had gait abnormalities, with
significantly irregular gait patterns compared with HRE-10 mice in
the stand, base of support (BOS), diagonal support and three
support parameters (Fig. 4A). When we assessed the hindlimb splay
in the two cohorts (HRE-10 and HRE-102), we found that there was
a significant defect in the right hindlimb in the HRE-102 mice
(Fig. 4B). These deficits did not appear to affect the exploratory
activity of the mice as HRE-102 mice were not significantly
different to HRE-10 mice in the open field at 12 months of
age (Fig. 4C). When we analysed data between 6 and 12 months of
age from several of the same tasks, we noted that most of the gait
parameters, including those measuring stride irregularities (stand,
swing, and swing speed), in addition to activity in the open field
showed significant deterioration with age in the HRE-102 mice
(Fig. S4A-D), demonstrating that the behavioural impairments in
HRE-102 mice were progressive. There were, however, no
differences between groups in the accelerating rotarod over the
10months of testing (Fig. S4E).We next used the object recognition
paradigm to determine whether the HRE-102 mice had any
cognitive deficits that could correlate with the CA1 dispersal
Fig. 1. AAV9 hexanucleotide RNA expansions (HREs) can generate RNA foci in themouse CNS. (A) Two different HREs were designed and subcloned into
AAV9 vectors with the (G4C2)102 expansions constructed using a mixture of (G4C2)10-17 oligonucleotides with an intervening linker sequence. (B-G) RNA
fluorescence in situ hybridization was used to detect RNA foci, which were abundant in the hippocampus (HC, B), cortex (CTX, C), cerebellum (CB, D) and
sparse in the spinal cord (SC, E). Asterisk in E indicates a motor neuron. The majority of the foci were intranuclear (D,E, white arrowheads), although
cytoplasmic (F, yellow arrowhead) and juxtanuclear foci (F,G, arrows) were detected. (H) Therewere no significant differences (NS) in the number of foci detected
per mm2 in either the HC, CTX or CB between HRE-10 and HRE-102 mice as assessed using an unpaired two-tailed Student’s t-test for each region (HRE-10,
n=6; HRE-102, n=6). Scale bar: 10 µm. Nuclei counterstained in blue with Hoechst 33342.
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demonstrated in Fig. 2D. This behavioural task exploits the innate
interest of mice to explore a novel object by forcing mice to
discriminate between a novel object and an object previously
explored. Both sets of mice explored two novel objects without any
significant difference in the familiarization phase (Fig. 4D), but
only HRE-102 mice were unable to discriminate between a novel
object and one they had previously explored, indicating the presence
of a memory deficit.
DISCUSSION
Current mouse models of C9orf72-related ALS/FTD have supported
a toxic gain-of-function mechanism by which long G4C2 HREs
induce the formation of intracellular RNA foci and RAN protein
aggregates, leading to toxicity and behavioural dysfunction. Here, we
used AAVs to express either 10 or 102 HREs containing regularly
spaced interruptions in mice, and demonstrate that while both lines of
mice have similar numbers of RNA foci dispersed through the brain,
only HRE-102 mice generate c9RAN pathology, exhibit NMJ
pathology, hippocampal CA1 dispersion, early markers of apoptosis,
and display gait and cognitive deficits.
To date, four independent mouse models expressing either full-
length or truncated human C9orf72 with hundreds of HREs have
been generated, along with an AAV-mediated model expressing a
reduced number (66) of HREs. All of these mouse models have
Fig. 2. Dipeptide protein repeat (DPR) pathology, hippocampal CA1 dispersal and upregulation of cell death markers are observed in HRE-102 mice.
(A) Cytoplasmic and nuclear DPRs adopt several morphologies in a subset of HRE-102 mice using a poly-GA antibody in cerebellar tissue. Arrows indicate nuclear
expression and arrowheads show discrete cytoplasmic staining. (B) Immunoblots of cerebellar lysates show that both Triton-soluble and Triton-insoluble
proteins contain GA-rich DPRs in HRE-102 mice that were never observed in HRE-10 mice. (C) HRE-102 mice show increased p62 expression in cerebellar tissue
compared with HRE-10 mice; arrowhead shows 60 kDa isoform that was consistently absent in HRE-10 brains. (D) p62 inclusions are evident in both the nucleus
(arrows) and cytoplasm (arrowheads) in the cerebellum of HRE-102 mice but are absent in HRE-10 mice. (E,F) A significant number of Purkinje cells in the
cerebellum of HRE-102 mice show signs of early apoptosis reflected by cleaved PARP immunoreactivity (n=4 for both, P=0.046). (G) Enhanced cleaved caspase-3
expression is observed in cerebellar lysates from HRE-102 mice. (H,I) There were no differences in the number of neurons as determined by NeuN staining in the
dentate gyrus (DG: HRE-10, n=4; HRE-102, n=6; P=0.66) or CA3 (HRE-10, n=4; HRE-102, n=6; P=0.69) in the hippocampus between HRE-10 and HRE-102, but
therewas a significant dispersal of CA1 neurons in HRE-102mice (HRE-10, n=4; HRE-102, n=6;P=0.046). Nuclei in H are counterstained bluewith Hoechst 33342.
All comparisons were made with an unpaired two-tailed Student’s t-test with Welch’s correction; mean±s.e.m. Scale bars: 10 µm (A,E,H) and 25 µm (D).
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detectable RNA foci and c9RAN aggregates in the brain, although
the minimum size necessary to induce RNA foci formation differs
widely. Expression of a full-length C9orf72 bacterial artificial
chromosome (BAC) transgene in mice was unable to induce RNA
foci formation with 36-37 HREs (Liu et al., 2016; O’Rourke et al.,
2015), and in mice expressing a truncated C9orf72, expression of
100 G4C2 expansions yield limited RNA foci (Jiang et al., 2016). In
contrast, AAV-mediated expression of 66 HREs with a constitutive
actin promoter generated significant ALS/FTD pathology, which
was absent when only 2 HREs were expressed (Chew et al., 2015).
We chose a higher minimum expansion length of 10 HREs to
determine whether we could cross the minimal threshold for
generating RNA foci without forming DPRs. Surprisingly, our mice
expressing HRE-10 showed similar numbers of RNA foci in the
CNS (Fig. 1H) to our mice expressing HRE-102, despite the
presence of DPRs in only the HRE-102 mice. We therefore
conclude that RNA foci density is not an accurate predictor of DPR
formation.
Fig. 3. Neuromuscular junction (NMJ) defects are present in the HRE-102 mice. (A,B) Abnormal neurofilament accumulation and nerve terminal blebbings
(arrows) are prominent in HRE-102mice (PBS, n=3; HRE-10, n=4; HRE-102, n=4; where n=individual muscles per genotype; F2,8=6.47, *P=0.02, post hocTukey:
HRE-10 vs PBS, P=0.19; HRE-10 vs HRE-102, P=0.23; HRE-102 vs PBS, P=0.02). Scale bar: 30 µm. (C,D) HRE-102 mice have a significant decrease in
acetylcholine receptor density compared with PBS-injected controls (F2,7=10.79, **P=0.007, post hoc Tukey: HRE-10 vs PBS, P=0.16; HRE-10 vs HRE-102,
P=0.056; HRE-102 vs PBS, P=0.006). The fluorescence intensity (total fluorescence of that synapse divided by the area of that given synapse) of a saturating
dose of α-bungarotoxin Alexa Fluor 594 was measured and normalized to PBS controls. All comparisons were made with a one-way ANOVA and post hoc
Tukey for comparisons between groups; mean±s.e.m. NS, not significant.
Fig. 4. Gait and cognitive deficits observed in HRE-102 mice are absent in HRE-10 mice in 12-month-old mice. (A) Gait abnormalities such as the front and
hind stand index, the hind base of support (BOS), the diagonal support and the three-legged support were observed using a Catwalk system in HRE-102 mice
(HRE-10, n=11; HRE-102, n=13 for each group; front stand, *P=0.04; hind stand, *P=0.04; front BOS,P=0.19; hind BOS, *P=0.02; diagonal support, *P=0.01; three-
legged support, **P=0.006). (B) HRE-102mice (n=13) had amoderate splay in the right (*P=0.04) but not left (P=0.59) hind limb comparedwithHRE-10mice (n=11).
(C) There were no significant differences (NS) in activity (P=0.15) between HRE-10 (n=11) and HRE-102 (n=13) in the open field. (D) An object recognition test
identified a cognitive deficit in HRE-102mice as they failed to discriminate in the testing phase (n=13; familiarization phase,P=0.43; testing phase,P=0.09) between
a novel object and an object previously explored in the familiarization phase unlike HRE-10 mice (n=11, familiarization phase, P=0.57; testing phase, *P=0.02).
All comparisons were made with an unpaired two-tailed Student’s t-test with Welch’s correction; mean±s.e.m. NS, not significant.
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The presence of poly-GA and p62 aggregates (Fig. 2A-D) in our
HRE-102 mice indicates that the interruptions we introduced
between every 10-17 GGGGCC repeats do not prevent DPR
formation. In contrast, interrupting AAV-mediated poly-GA
expression in mice with proline residues (Zhang et al., 2016) or
inserting stop codons between extended HREs expressed in
Drosophila melanogaster (Mizielinska et al., 2014) abolish DPR
formation and prevent other disease-related pathologies and
behavioural phenotypes. Our interrupted HRE-102 construct
shifted the reading frame of the translated sequence without
introducing a stop codon, resulting in the formation of mixed
dipeptides as opposed to single extended tracts of poly-GA, poly-
GR or poly-GP. We were unable to detect robust poly-GR or poly-
GP expression in our mice, although this is more likely to be due to
the cross-reactivity of our antibody to endogenous proteins in mouse
tissue, as a cell culture model expressing an inducible version of our
HRE-102 construct detected poly-GA, poly-GP and poly-GR DPRs
(Stopford et al., 2017).
Interruptions in C9orf72 expansions have not yet been described,
but interrupted repeat expansions have frequently been detected in
other neurological disorders, including spinocerebellar ataxia
(Chung et al., 1993), fragile X syndrome (Eichler et al., 1994),
myotonic dystrophy type I (Musova et al., 2009) and Friedreich
ataxia (Stolle et al., 2008). There is no consensus on the general
effects of the interruptions on disease progression, although there is
strong evidence that interruptions can stabilize DNA sequences and
prevent the formation of slipped DNA structures in CAG and CGG
repeat disorders (Eichler et al., 1994; Pearson et al., 1998a,b; Menon
et al., 2013). The more rapid development of ALS/FTD phenotypes
in the uninterrupted HRE-66 mice described by Chew et al. (2015)
compared with our interrupted HRE-102 may reflect a stabilizing
presence of our interruptions on the expansion sequence.
In large GAA expansions in Friedreich ataxia, interruptions can
stabilize the DNA sequence (Pollard et al., 2004) without
necessarily having any effect on the age of onset (Stolle et al.,
2008). In contrast, interruptions in the CTG expansions in myotonic
dystrophy type I delay disease onset and suppress the muscular
dystrophic phenotype (Musova et al., 2009), disruptions in the CGG
repeats of fragile X mental retardation 1 (FMR1) protect carriers
from premature ovarian failure (Bodega et al., 2006), and CAT
insertions between CAG expansions in the ataxin-1 gene (ATXN1)
prevent the development of the full SCA1 phenotype. There is also
evidence that interruptions can lead to the presentation of new
phenotypes as disruptions in the ATTCT repeats in SCA10 are
associated with a higher incidence of seizures (Matsuura et al.,
2006) and CAG repeats that normally cause SCA2 can lead to
parkinsonism when CAA triplets interrupt the CAG expansion
(Charles et al., 2007). As a result, it is difficult to draw conclusions
on the effects of the interruptions on disease progression in our AAV
HRE-102 mice, although it is notable that these mice develop some
of the pathologies and behavioural phenotypes consistent with ALS/
FTD, suggesting it is less likely that the interruptions led to a novel
phenotype. It also seems unlikely that the interruptions in our HRE-
102 mice disrupt protein aggregation as in the mice described by
Zhang et al. (2016), which harbour proline interruptions between
DPRs, as we detected clear poly-GA and p62 depositions in the
tissue (Fig. 2A-D).
We did not observe extensive TDP-43 pathology in either the
HRE-10 or HRE-102 mice, and the majority of TDP-43 depositions
were cytoplasmic (Fig. S3), which contrasts with the nuclear TDP-43
pathology in the HRE-66 mice described by Chew et al. (2015). The
relative paucity of TDP-43 aggregates in the nucleus of our HRE-102
mice may be due to the interruptions disrupting the G-quadruplexes
formed by pure G4C2 repeats and preventing the reported association
between the G-quadruplexes and mRNA export proteins SRSF1
(Reddy et al., 2013; Zamiri et al., 2014) and hnRNPs (Conlon et al.,
2016; Haeusler et al., 2014; Zamiri et al., 2014). We can also not rule
out the possibility that an uninterrupted RNA sequence influences
TDP-43 deposition as a result of increased toxicity. Future
investigations on the effects of interruptions on G-quadruplexes
and TDP-43 export will be necessary to clarify this.
As progressive deficits in spatial learning and memory and have
been reported in C9orf72 BAC transgenic mice expressing 450
repeats (Jiang et al., 2016), we carefully examined hippocampal
pathology in the AAV-mediated mouse models since our HRE-102
mice failed to discriminate between familiar and novel objects,
demonstrating the presence of a cognitive deficit (Fig. 4D).
Previously, DPRs in the hippocampal CA1 of patients with
C9orf72 repeats have been reported (Pletnikova et al., 2014), but
while wewere unable to detect DPR aggregates in the hippocampus,
we did observe a dispersal of the CA1 (Fig. 2H,I) in the HRE-102
mice that was reminiscent of the aberrant neuronal migration
phenotype of reeler (Disabled-1) mouse mutants that occurs during
early development (Trommsdorff et al., 1999; Howell et al., 1997).
Interestingly knockdown of Reelin, the glycoprotein absent in
reeler mutant mice, impairs rats in the object recognition task,
whereas Reelin overexpression can rescue deficits in the object
recognition task in mouse models of Alzheimer’s disease (Brosda
et al., 2011; Pujadas et al., 2014). Further analysis will be necessary
to determine whether any link between Reelin and C9orf72 exists.
In summary, these data support a HRE-length-dependent gain
of toxicity, with c9RAN formation being the likely driver of
pathogenesis because the gait, motor and cognitive deficits precede
any major TDP-43 pathology. AAV-mediated expression of 102
GGGGCC repeats in mice leads to significant disease-related
pathology despite the presence of interruptions leading to a mixture
of translated DPRs. Our model provides an interesting comparison
to similar AAV-mediated models expressing pure repeat
expansions, and may help uncouple the relationship between DPR
formation and disease pathophysiology.
MATERIALS AND METHODS
Antibodies and reagents
Rabbit anti-AAV VP1, VP2, VP3 (1:800, American Research Products, 03-
61084), rabbit anti-NeuN (1:500, Cell Signaling, clone D3S3I), rabbit anti-
GFAP (1:2000, Dako, Z0334), rabbit anti-TDP-43 (1:500, Proteintech, 18-
280-1-AP), mouse anti-TDP43-phospho Ser409/410-1 (1:4000, Cosmo
Bio, CAC-TIP-PTD-M01), mouse anti-Calbindin (1:1000, Sigma, C9848),
mouse anti-p62 lck ligand (1:1000 for WB, 1:250 for ICC, BD Biosciences,
clone 3, 610833), rabbit anti-α-tubulin (1:5000, Abcam, 4074), rabbit-
cleaved-caspase 3 (1:1000, Cell Signaling, 9661), mouse anti-cleaved
PARP (1:250, Cell Signaling, 9548), mouse anti-GAPDH (1:5000,
Calbiochem, CB 1001), mouse anti-poly(GA) [1:500 for WB, 1:5000 for
ICC, clone 5F2 (Mackenzie et al., 2013) kindly provided by Dieter Edbauer]
were used at the dilutions listed.
Cell lines and culture
HEK 293T cells were maintained in growth medium (GM) consisting of
Dulbecco’s modified Eagle’s medium (DMEM; Sigma, D5796)
supplemented with 10% fetal bovine serum (Sigma, USA), penicillin
(100 U/ml), and streptomycin (100 U/ml) at 37°C and 5% CO2.
Generation of repeat expansion constructs
Sense [TCGAC (G4C2)10] and antisense [ACGT(G4C2)10] oligonucleotides
(Sigma) with SalI/XhoI overhangs were annealed by denaturing at 95°C for
5 min and cooling at 0.5°C/min to 25°C. The dsDNA (G4C2)10 was ligated
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into SalI- and XhoI-digested pcDNA6.2-GW/EmGFP-miR (Invitrogen) to
generate pcDNA6.2-GW-(G4C2)10. Further (G4C2)n repeats where n varied
between 10 and 17 repeats were subcloned into the XhoI site to generate
the longer pcDNA6.2-(G4C2)102 construct. The (G4C2)10 and (G4C2)102
constructs were subsequently sub-cloned into a pAV2-CMV
(cytomegalovirus) plasmid and authenticity was confirmed by sequencing.
Transformations of plasmids containing the (G4C2)n repeat constructs were
performed using recombination-deficient β-10 E. coli (NEB) tominimize any
rearrangements.
Large-scale scAAV9 production
Sixty 15 cm plates containing HEK293 cells at 80% confluence were
transfected using polyethylenimine (MW∼25 K) with a mixture of three
plasmids required to generate an infectious scAAV9 viral particle: (1) a
plasmid providing helper genes isolated from adenovirus that enhance viral
infectivity (pHelper); (2) an ITR-containing a plasmid carrying the gene of
interest [pAV2-CMV-(G4C2)n; we used the pAV2-CMV-GFP consisting of
two ITRs in a truncated genome that resulted in a self-complementary
AAV9 (scAAV9), as described by others (McCarty et al., 2001)]; (3) a
plasmid that carries the AAV Rep-Cap proteins (pAAV2/9). Each 15 cm
plate was transfected with 40 µg DNA comprising a 2:1:1 molar ratio of
pHelper:pAV2-CMV-(G4C2)n:pAAV2/9. Four days after transfection, the
AAV-enriched medium was collected, incubated at 37°C for 2 h with 3750
units of benzonase nuclease (Sigma), filtered through a 0.22 µm filter, and
concentrated to a volume of 1 ml using Amicon spin filter units (Millipore).
The virus was then washed with 50 ml phosphate-buffered saline (PBS,
pH 7.3) in the same Amicon spin filter units, and concentrated to a final
volume of 0.5 ml. The viral sample volume was expanded to 14 ml with
PBS and separated through a discontinuous iodixanol (Sigma, D1556)
gradient (4 ml of 54%, 9 ml of 40%, 9 ml of 25%, 5 ml of 15%), and
centrifuged at 69,000 rpm for 1.5 h at 18°C. Phenol Red was added to the
54% and 25% iodixanol layers to help with identifying the virus-enriched
layer. The purified virus was found as a white layer between the 54% and
40% iodixanol gradient and subsequently removed in 0.5 ml fractions
using a syringe, with 10 µl of each fraction mixed at an equal ratio with 2×
reducing sample SDS-PAGE buffer, heated to 75°C for 20 min, separated
on a 4-20% precast TGX mini-gel (Bio-Rad), and stained with Sypro-
Ruby according to the manufacturer’s protocol (Life Technologies).
Fractions that showed a pure virus composed solely of the VP1, VP2 and
VP3 bands were combined, and washed against five full volumes (15 ml
each) of PBS with an Amicon spin filter, before collecting in a final
volume of between 300 and 500 µl.
Quantitative PCR to measure viral titres
Viral titres were determined with the Quantifast SyBR Green PCR Kit
(Qiagen, 204054) on a Bio-Rad CFX96 thermal cycler, following the
manufacturer’s instructions. The number of copies in three dilutions of a
purified AAV9 virus (1:100, 1:1000, 1:10,000) were compared with a
standard curve generated by serial dilutions of a linearized pAV2-CMV-
(G4C2)n vector. Primers used to quantify viral genomes were (PolyA,
Forward: 5′-ATT TTA TGT TTC AGG TTC AGG GGG AGG TG-3′),
(PolyA, Reverse: 5′-GCG CAG AGA GGG AGT GGA CTA GT-3′).
RNA fluorescence in situ hybridization (FISH)
RNA FISH was performed as described previously (Cooper-Knock et al.,
2014) with a few modifications. Briefly, a 5′ TYE-563-labelled LNA (16-
mer fluorescent)-incorporated DNA probe was used against the sense RNA
hexanucleotide repeat (Exiqon, batch number 607323). Coronal brain
sections (20 µm) directly cut onto slides were air dried, and then incubated
in ice-cold acetone for 10 min before washing in PBS. Slides were blocked
with a hybridization solution [50% formamide, 2× saline sodium citrate
(SSC), 100 mg/ml dextran sulphate, 50 mM sodium phosphate, pH 7.0] for
1 h at 66°C and then incubated with 400 ng/ml of denatured probe in
hybridization solution overnight at 66°C. After hybridization, slides were
washed once in 2×SSC/0.1% Tween-20 at room temperature and three times
in 0.1× SSC at 65°C and counterstained with Hoechst 33342. All solutions
were made with DEPC-treated water.
Generation of the AAV9-mediated mouse model
Mice were kept in a 12 h dark:12 h light cycle, with free access to food and
water and a standardized room temperature, based on the UK Home Office
Code of practice for the housing and care of animals used in scientific Act
1986. All in vivo experiments carried out in this study were performed
according to the Animal (Scientific Procedures) Act 1986, under Project
License 40/3739, and were approved by the University of Sheffield Ethical
Review Sub-committee and the UK Animal Procedures Committee
(London, UK).
Viruses [4.5×1010 vg; scAAV9-CMV-(G4C2)10 or scAAV9-CMV-
(G4C2)102] were injected into the cerebrospinal fluid (CSF) of postnatal 1
(P1) C57BL/6J wild-type mice, via the cisterna magna, under general
anaesthesia. Pups from the same breeding pair were allocated randomly to
the experimental groups. Viral delivery was carried out following the
protocol described previously (Lukashchuk et al., 2016). Briefly, pups were
anaesthetized in an induction chamber using 5% isoflurane and oxygen at
3 l/min before placing the animal over a red transilluminator in the prone
position. Viruses were loaded in a Hamilton syringe attached to a peristaltic
pump and injected into the cisterna magna, using a stereotaxic apparatus, at a
flow rate of 1 µl/min to a maximum volume of 5 µl. Anaesthesia was
maintained with 2% isoflurane and oxygen at 0.3 l/min during the injection.
Immunohistochemistry
Twelve months after injection, animals were euthanized under terminal
anaesthesia and transcardially perfused using a solution of PBS-heparin
followed by 4% paraformaldehyde (PFA) in PBS. Brain and spinal cords
were harvested and further post-fixed overnight in 4% PFA. After fixation,
tissue was washed with PBS, cryoprotected in 30% of sucrose at 4°C,
embedded in OCT (Cell Path) and snap frozen in liquid nitrogen. Brains and
spinal cords were cut in 20-μm-thick coronal sections on a cryostat (Leica),
placed directly onto silane-treated slides, and then air dried. Sections were
incubated with gentle agitation for 2 h at room temperature in blocking
buffer (PBS with 5% normal goat serum, 3% BSA and 0.2% Triton X-100)
before incubating overnight at 4°C with the appropriate antibody diluted in
PBS with 3% BSA. Following three washes with PBS, sections were
incubated with an appropriate Alexa fluorophore-conjugated secondary
antibody (1:1000; Invitrogen) for 1 h at room temperature, counterstained
with Hoechst 33342 and mounted onto slides with Fluoromount (Sigma).
For visualizing DPR pathology, slides were immersed in sodium citrate
buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) for 30 min at 60°C
before the blocking step. We used a Nissl stain (0.1% Cresyl Fast Violet;
BDH, Lutterworth, UK) on spinal cord sections for counting motor neurons,
and in cerebellar brain sections for visualizing p62 expression.
Neuromuscular junction (NMJ) pathology
NMJ pathology was assessed on whole-mount immunohistochemically
labelled preparations of hind paw lumbrical muscles from 1-year-old mice,
as described previously (Powis et al., 2016; Wishart et al., 2014). Images
were captured using a Nikon A1R confocal system combined with a Ti:E
inverted microscope (×60 objective). Individual NMJs were assessed and
abnormalities quantified by eye for evidence of neuromuscular pathology
(presence of axonal blebbing/thinning or abnormal neurofilament
accumulations in distal motor axons and/or motor nerve terminals). NMJ
analysis was performed by investigators blinded to the treatment group.
Quantitative fluorescence imaging
To assess the effect of CG repeats on the postsynaptic receptor density (marker
of synapses), muscle cells were labelled with a saturating dose of fluorescent
bungarotoxin (BTX) (5 μg/ml, ∼1 h) and images of NMJs were collected
using IPLAB software as described previously (Akaaboune et al., 1999;
Martinez-Pena et al., 2015). The fluorescence intensity of labelled AChRs
was analysed with algorithms for MATLAB (MathWorks). Background
fluorescencewas determined bymanual selection of a boundary region around
each NMJ and subtracting it from the original image, and the mean of the total
fluorescence intensity (which corresponds to total fluorescence of that synapse
divided by the area of that given synapse) was measured (Turney et al., 1996;
Akaaboune et al., 1999; Martinez-Pena et al., 2015).
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Immunoblotting
Adult mice were euthanized using an overdose of sodium pentobarbitol, and
brains were rapidly dissected and snap frozen with liquid nitrogen. Brains
were then homogenized in RIPA buffer using a glass Dounce homogenizer
[150 mMNaCl, 50 mM Tris-HCl (pH 8), 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulphate (SDS), 1% NP-40 supplemented with 1X EDTA-
free protease inhibitor cocktail (Roche)] for 30 min on ice and centrifuged at
17,000 g at 4°C for 10 min. Supernatant was then collected as a cytoplasmic
fraction and used to examine p62 reactivity. To examine poly-GADPRs, the
membrane-enriched pellet was further solubilized in a buffer containing 1%
Triton X-100 and 0.5 MNaCl in 10 mMTris-HCl (pH 7.4) for 45 min at 4°C
with constant agitation and centrifuged at 17,000 g at 4°C for 10 min.
Supernatant was collected as the triton-soluble fraction and the pellet was
re-suspended in a buffer containing 2%SDS in 10 mMTris-HCl (pH 7.4) and
stored as the Triton-insoluble fraction. Protein lysates were mixed with a
4× Laemmli buffer with 5% β-mercaptoethanol, heated to 95°C for 5 min,
separated by 10% SDS-PAGE and transferred onto a PVDF membrane
(Millipore). Membranes were blocked with either 5% BSA or 5% non-fat dry
milk in TBS with 0.05% Tween (TBST) for 30 min, before incubating at 4°C
overnight with agitation with the appropriate antibody diluted in 5% BSA in
TBST. Following three washes in TBST for 10 min each, membranes were
incubated at room temperature with mild agitation with an appropriate
secondary HRP antibody (Sigma, 1:5000) diluted in 5% BSA in TBST,
washed three times with TBST for 10 min each, and developedwith enhanced
chemiluminescent substrate (Amersham-Pharmacia Biotech).
Mouse behavioural tests
All mouse behavioural experiments were performed with the experimenter
blind to the mouse cohort groups.
Open field
The open field was a 60 cm×40 cm×25 cm semi-transparent plastic box with
a grid of 3×5 squares drawn on the underside of the box with black paint.
Open field activity was measured in a room with minimal light for 10 min
with the number of squares crossed recorded. A square crossing was defined
as the passage of all four mouse paws over one of the boundaries of a square.
Object recognition
Mice were tested for their ability to remember novel objects using a
paradigm described by others (Leger et al., 2013). Briefly, on day 1, mice
were habituated in a rectangular 60 cm×40 cm×25 cm open field for 3 min.
On the second day, mice were placed in the same box with two identical
objects, and allowed to explore until a total of 20 s of exploration between
the two objects had elapsed. Exploration was defined as mice actually
sniffing, biting, touching with paws or examining the object. On the third
day, one of the objects was replaced with a novel object, and the time
measured at each object was recorded until a total of 20 s had elapsed. To
make sure that the objects were interesting enough to entice mice to explore
them, the first object was a standard red capped 75 cm2 tissue culture flask
(Sigma, C7231) filled with a layer of purple dye treated agarose, while the
second object was a stack of red slide boxes taped together.
Gait analysis
To analyse the gait pattern, 6- and 12-month-old mice were placed on the
Catwalk XT (Noldus, The Netherlands), where they had to traverse a narrow
chamber in the dark. Their footprints were automatically recorded with
Catwalk 7.1 software from Noldus. Six runs were performed per animal and
the three best (chosen for mice walking along the chamber path as opposed
to repeatedly stopping) were selected for analysis. All results are expressed
as the mean of three runs±s.e.m. The following parameters were measured
and defined: (1) Stand: the time the paws spends in contact with the Catwalk
surface. (2) Base of support (BOS): distance between either the front or hind
paws. (3) Diagonal support: time spent on the Catwalk surface by a front
paw and its opposing hind paw simultaneously (right front paw–left hind
paw). (4) Three support: time spent on the Catwalk surface by three paws at
the same time to support animal. (5) Swing: time between two consecutive
placements in which the paw is not in contact with the Catwalk surface.
(6) Swing speed: this parameter is calculated by dividing the stride length by
the swing phase duration.
Hind limb splay
Twelve-month-old mice were suspended by the tail and the splay defects
were observed and scored for right and left hind limbs by using the
following scale: 0: normal splay; 1: mild defect; 2: moderate defect; 3:
strong defect; 4: paralysed, as previously described (Mead et al., 2011). The
results show the mean of each group±s.e.m.
Rotarod
Performance on the rotarod (Ugo Basile, 7650) was assessed every 2 weeks,
twice per day, beginning 2 months after injection.Micewere initially trained
for 3 consecutive days before the first trial. The rotarod was set to accelerate
from 3 to 37 rpm in 300 s and the maximum time spent on the rotarod in a
single trial out of two trials tested was recorded.
Statistical analysis
Results are shown as mean±s.e.m. Student’s unpaired t-test with a Welch’s
correction for two group comparisons was used to assess differences
between HRE-10 and HRE-102 mice. For comparisons between three
groups (PBS injected, HRE-10 and HRE-102 mice), a one-way analysis of
variance (ANOVA) was used with Tukey’s multiple comparison post hoc
test when P<0.05. For assessing the effects of age on the gait and activity in
each mouse cohort, we used a two-way ANOVA with a Šidák’s test for
multiple comparisons when P<0.05. For all tests, a P <0.05 was taken as
statistically significant, and GraphPad Prism 6 was used for all statistical
analyses.
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